| Literature DB >> 34045473 |
Si-Ying Li1, He-Shou Lei1, Xiao-Yun Wu1, Kai Li1, Zhi-Min Liu1, Jian-Hui Lu1, Xiao-Yun Chen2.
Abstract
This study aimed to investigate the association between cognitive impairment after general anesthesia and rs55763075 polymorphisms. We enrolled and grouped patients undergoing general anesthesia according to their genotypes of rs55763075 polymorphism. Mini-Mental State Examination (MMSE) scoring was performed to evaluate the cognitive status of patients. Quantitative real-time PCR was carried out to analyze the expression of methylenetetrahydrofolate reductase (MTHFR) mRNA and miR-34b while Western blot was performed to evaluate the expression of MTHFR protein. Furthermore, we studied the effect of rs55763075 polymorphism on the expression of MEHFR via luciferase assay. Accordingly, we found that the MMSE score in GG/GA groups was significantly higher than that in AA group. And a significant reduction of MTHFR mRNA expression was observed in the serum and peripheral blood mononuclear cells (PBMCs) of patients carrying AA genotype compared with the patients carrying GG/GA genotypes. Moreover, the MTHFR expression was much lower in the cultured AA-genotyped cells transfected with miR-34b. Luciferase assay results also showed that miR-34b transfection reduced luciferase activity in the cells carrying A allele but not in cells carrying G allele. In summary, the data of this study showed that minor allele (A) of rs55763075 polymorphisms in the 3'-untranslated region of MTHFR mRNA generated a potential binding site for miR-34b, which led to reduced level of folic acid in the patients carrying the AA genotype. Furthermore, we found that the MMSE score of AA-genotyped patients was lower than that of patients carrying GG/GA genotypes.Entities:
Year: 2021 PMID: 34045473 PMCID: PMC8159953 DOI: 10.1038/s41598-021-90229-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Basic information of participants recruited in this study.
| Characteristics | GG (N = 79) | GA (N = 89) | AA (N = 25) | |
|---|---|---|---|---|
| Age, year | 69.54 ± 5.62 | 68.94 ± 5.75 | 71.54 ± 4.85 | 0.734 |
| Weight (kg) | 58.82 ± 6.64 | 59.45 ± 7.78 | 58.54 ± 8.45 | 0.543 |
| Sex, male | 35 (44.3) | 45 (50.6) | 17 (68.0) | 0.242 |
| Length of anesthesia (h) | 3.09 ± 0.29 | 3.16 ± 0.14 | 3.09 ± 0.28 | 0.622 |
| Past medical history | No serious heart lung diseases. Hepatic or renal dysfunction | |||
Figure 1The MMSE score was significantly lower for patients carrying AA alleles.
Figure 2Polymorphism at rs55763075 was correlated with folic acid and Hcy concentrations in the peripheral blood of patients who had received general anesthesia. (A) The concentration of folic acid was lower in the peripheral blood of patients carrying AA alleles. (B) The concentration of Hcy was higher in the peripheral blood of patients carrying AA alleles.
Figure 3The expression of MTHFR mRNA was decreased in the serum and PBMCs of patients carrying AA alleles of rs55763075. (A) MTHFR mRNA expression was notably diminished in the serum of patients carrying AA alleles. (B) No obvious difference was observed for the expression of miR-34b in the serum of patients carrying different genotypes. (C) MTHFR mRNA expression was notably diminished in the PBMCs of patients carrying AA alleles. (D) No obvious difference was observed for the expression of miR-34b in the PBMCs of patients carrying different genotypes.
Figure 4MiR-34b inhibited the luciferase activity of MTHFR-3’UTR-A (* P value < 0.05 vs. NC group). (A) Sequence analysis indicated potential binding of miR-34b to the 3’ UTR of MTHFR containing rs55763075. (B) The luciferase activity of MTHFR-3’UTR-A was effectively suppressed by miR-34b in THP-1 cells. (C) The luciferase activity of MTHFR-3’UTR-A was effectively suppressed by miR-34b in Hep G2 cells.
Figure 5MiR-34b precursors suppressed the expression of MTHFR mRNA and protein in the primary PBMCs of patients carrying AA genotype of rs55763705 rather than in the primary PBMCs of patients carrying GG genotype of rs55763705 (*P value < 0.05 vs. NC group). (A) The expression of MTHFR mRNA was inhibited by miR-34b precursors and MTHFR siRNA in primary PBMCs of patients carrying AA genotype of rs55763705. (B) The expression of MTHFR protein was inhibited by miR-34b precursors and MTHFR siRNA in primary PBMCs of patients carrying AA genotype of rs55763705. (C) The expression of MTHFR mRNA was not affected by miR-34b precursors in primary PBMCs of patients carrying GG genotype of rs55763705. (D): The expression of MTHFR protein was not affected by miR-34b precursors in primary PBMCs of patients carrying GG genotype of rs55763705. (the original WB blots were included in Supplementary files)